These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30125800)

  • 1. Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy.
    Sargos P; Baumann BC; Eapen L; Christodouleas J; Bahl A; Murthy V; Efstathiou J; Fonteyne V; Ballas L; Zaghloul M; Roubaud G; Orré M; Larré S
    Cancer Treat Rev; 2018 Nov; 70():88-97. PubMed ID: 30125800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.
    Orré M; Latorzeff I; Fléchon A; Roubaud G; Brouste V; Gaston R; Piéchaud T; Richaud P; Chapet O; Sargos P
    PLoS One; 2017; 12(4):e0174978. PubMed ID: 28384195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapy.
    Murthy V; Bakshi G; Manjali JJ; Prakash G; Pal M; Joshi A; Dholakia K; Bhattacharjee A; Talole S; Puppalwar A; Srinivasan S; Panigrahi G; Salunkhe R; Menon S; Noronha V; Prabhash K; Krishnatry R
    Urol Oncol; 2021 Aug; 39(8):496.e9-496.e15. PubMed ID: 33573998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial.
    Fonteyne V; Dirix P; Junius S; Rammant E; Ost P; De Meerleer G; Swimberghe M; Decaestecker K
    BMC Cancer; 2017 May; 17(1):308. PubMed ID: 28464906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
    Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial.
    Fonteyne V; Dirix P; Van Praet C; Berghen C; Albersen M; Junius S; Liefhooghe N; Noé L; De Meerleer G; Ost P; Villeirs G; Verbeke S; De Maeseneer D; Rammant E; Verghote F; Elhaseen E; De Man K; Decaestecker K
    Eur Urol Focus; 2022 Sep; 8(5):1238-1245. PubMed ID: 34893458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.
    Baumann BC; Guzzo TJ; He J; Vaughn DJ; Keefe SM; Vapiwala N; Deville C; Bekelman JE; Tucker K; Hwang WT; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):363-9. PubMed ID: 22658217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer].
    Pignot G; Sargos P
    Prog Urol; 2021 Mar; 31(3):158-168. PubMed ID: 33358467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy.
    D'Rummo KA; TenNapel MJ; Shen X
    Am J Clin Oncol; 2019 Sep; 42(9):705-710. PubMed ID: 31368905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
    Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G
    Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.
    Reddy AV; Pariser JJ; Pearce SM; Weichselbaum RR; Smith ND; Steinberg GD; Liauw SL
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1031-9. PubMed ID: 27026309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
    Sargos P; Baumann BC; Eapen LJ; Bahl A; Murthy V; Roubaud G; Orré M; Efstathiou JA; Shariat S; Larré S; Richaud P; Christodouleas JP
    Transl Androl Urol; 2016 Oct; 5(5):702-710. PubMed ID: 27785427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathological pelvic lymph node involvement in muscle-invasive bladder cancer patients treated with radical cystectomy: A narrative review].
    Gabriel PE; Pinar U; Parra J; Vaessen C; Mozer P; Chartier-Kastler E; Rouprêt M; Seisen T
    Prog Urol; 2023 Mar; 33(3):145-154. PubMed ID: 36604248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.
    Mari A; Kimura S; Foerster B; Abufaraj M; D'Andrea D; Gust KM; Shariat SF
    Urol Oncol; 2018 Jun; 36(6):293-305. PubMed ID: 29685374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?].
    Sargos P; Larré S; Chapet O; Latorzeff I; Fléchon A; Roubaud G; Orré M; Belhomme S; Richaud P
    Cancer Radiother; 2017 Feb; 21(1):67-72. PubMed ID: 28187997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer.
    Murthy V; Maitre P; Singh M; Pal M; Arora A; Pujari L; Kapoor A; Pandey H; Sharma R; Gudipudi D; Joshi A; Prabhash K; Noronha V; Menon S; Mehta P; Bakshi G; Prakash G
    Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e506-e515. PubMed ID: 37208232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
    Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
    Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
    Necchi A; Pond GR; Moschini M; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Vaishampayan U; Theodore C; Sridhar SS; Rosenberg JE; Bellmunt J; Gallina A; Colombo R; Montorsi F; Briganti A; Galsky MD
    Clin Genitourin Cancer; 2019 Feb; 17(1):7-14.e3. PubMed ID: 30292628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.